Genetic determinants of coxsackievirus B3 pathogenesis

被引:16
|
作者
McManus, BM
Yanagawa, B
Rezai, N
Luo, HL
Taylor, L
Zhang, M
Yuan, J
Buckley, J
Triche, T
Schreiner, G
Yang, DC
机构
[1] UBC, St Pauls Hosp Prov Hlth Care, Dept Pathol & Lab Med, McDonald Res Lab,iCAPTRE Ctr, Vancouver, BC V6Z 146, Canada
[2] Childrens Hosp, Los Angeles, CA 90027 USA
[3] Scios Inc, Sunnyvale, CA USA
关键词
genomic analysis; coxsackievirus B3; genetics; infectomics;
D O I
10.1111/j.1749-6632.2002.tb05950.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The development of high throughput genomic and bioinformatic analysis tools, coupled with established molecular techniques, has allowed new insights into the pathogenesis of infectious diseases. In humans, coxasackievirus B3 (CVB3) is the primary etiological agent of viral myocarditis, an inflammatory disease process involving the heart muscle. Early host cellular survival and apoptotic mechanisms during viral infections, as well as immune events, affect myocarditis progression and outcome. Therefore, our laboratory has been keenly interested in infectomics, defined here as the transcriptional events of both virus and host. We first elucidated up- or downregulated transcriptional activities in CVB3-infected hearts by mRNA differential display. Further characterization of these regulated genes including Nip21, IP10, and IGTPase, and study of their role in CVB3-infection are underway. In further dissection of the stages of myocarditis-peak viremia, inflammatory infiltration and tissue repair-we used cDNA microarrays to probe differential gene expression in the myocardium following virus infection. Following virus infection, there are global decreases in metabolic and mitochondrial genes, increases in signaling genes and distinctive patterns in other functional groups. To,establish early gene expression profiles in infected cells by themselves, we also used oligonucleotide arrays in an in vitro model of CVB3 infection. Notably, we have found increased expression of transcription factors c-fos and c-jun downstream of extracellular signal-related kinase, a pathway which is crucial for virus replication and pathogenesis. Our investigations based on gene profiling following CVB3 infection have thus far been fruitful in providing new experimental leads. High throughput genetic analysis has allowed us to simultaneously try on greater, than 12,000 potential genetic "glass slippers." Our in vitro experimental plan has enabled us to chart prominent patterns of gene expression, analyzed by novel bioinformatic approaches, and to separate varied and potentially significant gene expression events.
引用
收藏
页码:169 / 179
页数:11
相关论文
共 50 条
  • [31] Ubiquitination Is Required for Effective Replication of Coxsackievirus B3
    Si, Xiaoning
    Gao, Guang
    Wong, Jerry
    Wang, Yahong
    Zhang, Jingchun
    Luo, Honglin
    [J]. PLOS ONE, 2008, 3 (07):
  • [32] Treatment of neonatal infection caused by coxsackievirus B3
    Kimura H.
    Minakami H.
    Harigaya A.
    Takeuchi H.
    Tachibana A.
    Otsuki K.
    [J]. Journal of Perinatology, 1999, 19 (5) : 388 - 390
  • [33] Colchicine aggravates coxsackievirus B3 infection in mice
    Emmens, R.
    Smilde, B. J.
    Woudstra, L.
    Hing, G. Fong
    Wouters, D.
    Zeerleder, S.
    Murk, J. L.
    Van Ham, S. M.
    Heymans, S.
    Juffermans, L. J. M.
    Van Rossum, A. C.
    Niessen, J. W. M.
    Krijnen, P. A. J.
    [J]. EUROPEAN HEART JOURNAL, 2016, 37 : 1195 - 1195
  • [34] Genomic regions of coxsackievirus B3 associated with cardiovirulence
    Lee, C
    Maull, E
    Chapman, N
    Tracy, S
    Gauntt, C
    [J]. JOURNAL OF MEDICAL VIROLOGY, 1997, 52 (03) : 341 - 347
  • [35] Nucleotide differences of coxsackievirus B3 and chronic myocarditis
    Chiharu Kishimoto
    Nami Takamatsu
    Hiroshi Ochiai
    Kagemasa Kuribayashi
    [J]. Heart and Vessels, 2015, 30 : 126 - 135
  • [36] Cardiomyocyte apoptosis in experimental coxsackievirus B3 myocarditis
    Saraste, A
    Arola, A
    Vuorinen, T
    Kytö, V
    Kallajoki, M
    Pulkki, K
    Voipio-Pulkki, LM
    Hyypiä, T
    [J]. CARDIOVASCULAR PATHOLOGY, 2003, 12 (05) : 255 - 262
  • [37] Colchicine aggravates coxsackievirus B3 infection in mice
    Smilde, Bernard J.
    Woudstra, Linde
    Hing, Gene Fong
    Wouters, Diana
    Zeerleder, Sacha
    Murk, Jean-Luc
    van Ham, Marieke
    Heymans, Stephane
    Juffermans, Lynda J. M.
    van Rossum, Albert C.
    Niessen, Hans W. M.
    Krijnen, Paul A. J.
    Emmens, Reindert W.
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 216 : 58 - 65
  • [38] Inhibition of coxsackievirus B3 by RNA interference (RNAi)
    J Kurreck
    S Schubert
    D Werk
    D Rothe
    HP Grunert
    I Sipo
    H Fechner
    W Poller
    VA Erdmann
    H Zeichhardt
    [J]. Retrovirology, 3 (Suppl 1)
  • [39] Colchicine aggravates coxsackievirus B3 infection in mice
    Emmens, R. W.
    Smilde, B. J.
    Woudstra, L.
    Hing, G. Fong
    Wouters, D.
    Zeerleder, S.
    Murk, J. L.
    Van Ham, S. M.
    Heymans, S.
    Juffermans, L. J. M.
    Van Rossum, A. C.
    Niessen, J. W. M.
    Krijnen, P. A. J.
    [J]. CARDIOVASCULAR RESEARCH, 2016, 111 : S113 - S113
  • [40] Ubiquitination is required for effective replication of coxsackievirus B3
    Si, XN
    Gan, G
    Zhang, JC
    Wang, J
    Wang, YH
    McManus, BM
    Luo, HL
    [J]. FASEB JOURNAL, 2006, 20 (04): : A644 - A644